281 related articles for article (PubMed ID: 26733416)
1. RPS23RG1 reduces Aβ oligomer-induced synaptic and cognitive deficits.
Yan L; Chen Y; Li W; Huang X; Badie H; Jian F; Huang T; Zhao Y; Cohen SN; Li L; Zhang YW; Luo H; Tu S; Xu H
Sci Rep; 2016 Jan; 6():18668. PubMed ID: 26733416
[TBL] [Abstract][Full Text] [Related]
2. The Rps23rg gene family originated through retroposition of the ribosomal protein s23 mRNA and encodes proteins that decrease Alzheimer's beta-amyloid level and tau phosphorylation.
Huang X; Chen Y; Li WB; Cohen SN; Liao FF; Li L; Xu H; Zhang YW
Hum Mol Genet; 2010 Oct; 19(19):3835-43. PubMed ID: 20650958
[TBL] [Abstract][Full Text] [Related]
3. A functional mouse retroposed gene Rps23r1 reduces Alzheimer's beta-amyloid levels and tau phosphorylation.
Zhang YW; Liu S; Zhang X; Li WB; Chen Y; Huang X; Sun L; Luo W; Netzer WJ; Threadgill R; Wiegand G; Wang R; Cohen SN; Greengard P; Liao FF; Li L; Xu H
Neuron; 2009 Nov; 64(3):328-40. PubMed ID: 19914182
[TBL] [Abstract][Full Text] [Related]
4. Effects of the neurotrophic agent T-817MA on oligomeric amyloid-β-induced deficits in long-term potentiation in the hippocampal CA1 subfield.
Takamura Y; Ono K; Matsumoto J; Yamada M; Nishijo H
Neurobiol Aging; 2014 Mar; 35(3):532-6. PubMed ID: 24112791
[TBL] [Abstract][Full Text] [Related]
5. Tripchlorolide improves cognitive deficits by reducing amyloid β and upregulating synapse-related proteins in a transgenic model of Alzheimer's Disease.
Zeng Y; Zhang J; Zhu Y; Zhang J; Shen H; Lu J; Pan X; Lin N; Dai X; Zhou M; Chen X
J Neurochem; 2015 Apr; 133(1):38-52. PubMed ID: 25661995
[TBL] [Abstract][Full Text] [Related]
6. Accumulation of intraneuronal β-amyloid 42 peptides is associated with early changes in microtubule-associated protein 2 in neurites and synapses.
Takahashi RH; Capetillo-Zarate E; Lin MT; Milner TA; Gouras GK
PLoS One; 2013; 8(1):e51965. PubMed ID: 23372648
[TBL] [Abstract][Full Text] [Related]
7. Abeta exacerbates the neuronal dysfunction caused by human tau expression in a Drosophila model of Alzheimer's disease.
Folwell J; Cowan CM; Ubhi KK; Shiabh H; Newman TA; Shepherd D; Mudher A
Exp Neurol; 2010 Jun; 223(2):401-9. PubMed ID: 19782075
[TBL] [Abstract][Full Text] [Related]
8. Postsynaptic degeneration as revealed by PSD-95 reduction occurs after advanced Aβ and tau pathology in transgenic mouse models of Alzheimer's disease.
Shao CY; Mirra SS; Sait HB; Sacktor TC; Sigurdsson EM
Acta Neuropathol; 2011 Sep; 122(3):285-92. PubMed ID: 21630115
[TBL] [Abstract][Full Text] [Related]
9. Pyruvate prevents the development of age-dependent cognitive deficits in a mouse model of Alzheimer's disease without reducing amyloid and tau pathology.
Isopi E; Granzotto A; Corona C; Bomba M; Ciavardelli D; Curcio M; Canzoniero LM; Navarra R; Lattanzio R; Piantelli M; Sensi SL
Neurobiol Dis; 2015 Sep; 81():214-24. PubMed ID: 25434488
[TBL] [Abstract][Full Text] [Related]
10. A mouse model of amyloid beta oligomers: their contribution to synaptic alteration, abnormal tau phosphorylation, glial activation, and neuronal loss in vivo.
Tomiyama T; Matsuyama S; Iso H; Umeda T; Takuma H; Ohnishi K; Ishibashi K; Teraoka R; Sakama N; Yamashita T; Nishitsuji K; Ito K; Shimada H; Lambert MP; Klein WL; Mori H
J Neurosci; 2010 Apr; 30(14):4845-56. PubMed ID: 20371804
[TBL] [Abstract][Full Text] [Related]
11. Propranolol reduces cognitive deficits, amyloid and tau pathology in Alzheimer's transgenic mice.
Dobarro M; Gerenu G; Ramírez MJ
Int J Neuropsychopharmacol; 2013 Nov; 16(10):2245-57. PubMed ID: 23768694
[TBL] [Abstract][Full Text] [Related]
12. Accelerated tau pathology with synaptic and neuronal loss in a novel triple transgenic mouse model of Alzheimer's disease.
Saul A; Sprenger F; Bayer TA; Wirths O
Neurobiol Aging; 2013 Nov; 34(11):2564-73. PubMed ID: 23747045
[TBL] [Abstract][Full Text] [Related]
13. Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers I: Abeta 42 oligomer binding to specific neuronal receptors is displaced by drug candidates that improve cognitive deficits.
Izzo NJ; Staniszewski A; To L; Fa M; Teich AF; Saeed F; Wostein H; Walko T; Vaswani A; Wardius M; Syed Z; Ravenscroft J; Mozzoni K; Silky C; Rehak C; Yurko R; Finn P; Look G; Rishton G; Safferstein H; Miller M; Johanson C; Stopa E; Windisch M; Hutter-Paier B; Shamloo M; Arancio O; LeVine H; Catalano SM
PLoS One; 2014; 9(11):e111898. PubMed ID: 25390368
[TBL] [Abstract][Full Text] [Related]
14. A critical role for the PAR-1/MARK-tau axis in mediating the toxic effects of Aβ on synapses and dendritic spines.
Yu W; Polepalli J; Wagh D; Rajadas J; Malenka R; Lu B
Hum Mol Genet; 2012 Mar; 21(6):1384-90. PubMed ID: 22156579
[TBL] [Abstract][Full Text] [Related]
15. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
Clausen A; Xu X; Bi X; Baudry M
J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
[TBL] [Abstract][Full Text] [Related]
16. Is interaction of amyloid β-peptides with metals involved in cognitive activity?
Tamano H; Takeda A
Metallomics; 2015 Aug; 7(8):1205-12. PubMed ID: 25959547
[TBL] [Abstract][Full Text] [Related]
17. Altered synaptic structure in the hippocampus in a mouse model of Alzheimer's disease with soluble amyloid-β oligomers and no plaque pathology.
Price KA; Varghese M; Sowa A; Yuk F; Brautigam H; Ehrlich ME; Dickstein DL
Mol Neurodegener; 2014 Oct; 9():41. PubMed ID: 25312309
[TBL] [Abstract][Full Text] [Related]
18. CIP2A Causes Tau/APP Phosphorylation, Synaptopathy, and Memory Deficits in Alzheimer's Disease.
Shentu YP; Huo Y; Feng XL; Gilbert J; Zhang Q; Liuyang ZY; Wang XL; Wang G; Zhou H; Wang XC; Wang JZ; Lu YM; Westermarck J; Man HY; Liu R
Cell Rep; 2018 Jul; 24(3):713-723. PubMed ID: 30021167
[TBL] [Abstract][Full Text] [Related]
19. Synergistic effects of amyloid-beta and wild-type human tau on dendritic spine loss in a floxed double transgenic model of Alzheimer's disease.
Chabrier MA; Cheng D; Castello NA; Green KN; LaFerla FM
Neurobiol Dis; 2014 Apr; 64():107-17. PubMed ID: 24440055
[TBL] [Abstract][Full Text] [Related]
20. Amyloid-β/Fyn-induced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of Alzheimer's disease.
Roberson ED; Halabisky B; Yoo JW; Yao J; Chin J; Yan F; Wu T; Hamto P; Devidze N; Yu GQ; Palop JJ; Noebels JL; Mucke L
J Neurosci; 2011 Jan; 31(2):700-11. PubMed ID: 21228179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
